Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Embecta Corp. stock logo
EMBC
Embecta
$9.64
+3.9%
$11.04
$9.20
$21.48
$563.36M1.13489,555 shs1.09 million shs
LivaNova PLC stock logo
LIVN
LivaNova
$45.75
-0.1%
$42.68
$32.48
$57.35
$2.49B0.9636,245 shs703,642 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$82.57
+0.2%
$83.66
$71.42
$109.58
$1.87B0.83169,389 shs230,472 shs
Envista Holdings Corporation stock logo
NVST
Envista
$19.69
+0.2%
$17.80
$14.22
$23.00
$3.34B0.992.49 million shs2.56 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Embecta Corp. stock logo
EMBC
Embecta
0.00%-1.33%-9.23%-24.39%-22.88%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%+0.53%+5.93%+16.47%-16.55%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.00%+0.97%+0.49%-1.59%+0.35%
Envista Holdings Corporation stock logo
NVST
Envista
0.00%+4.29%+7.63%+13.73%+18.37%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Embecta Corp. stock logo
EMBC
Embecta
4.424 of 5 stars
3.21.03.30.01.93.33.8
LivaNova PLC stock logo
LIVN
LivaNova
2.858 of 5 stars
3.53.00.00.01.61.71.3
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.5041 of 5 stars
2.21.03.30.02.32.51.3
Envista Holdings Corporation stock logo
NVST
Envista
3.4248 of 5 stars
2.23.00.03.81.50.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Embecta Corp. stock logo
EMBC
Embecta
2.33
Hold$19.33100.55% Upside
LivaNova PLC stock logo
LIVN
LivaNova
3.00
Buy$59.2929.59% Upside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.33
Hold$97.8318.49% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.33
Hold$20.232.77% Upside

Current Analyst Ratings Breakdown

Latest EMBC, NVST, LIVN, and LMAT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2025
Envista Holdings Corporation stock logo
NVST
Envista
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/27/2025
Envista Holdings Corporation stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$21.00 ➝ $23.00
5/23/2025
Embecta Corp. stock logo
EMBC
Embecta
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$25.00
5/23/2025
Embecta Corp. stock logo
EMBC
Embecta
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.00
5/20/2025
LivaNova PLC stock logo
LIVN
LivaNova
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$60.00
5/13/2025
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$64.00 ➝ $64.00
5/8/2025
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$56.00 ➝ $55.00
5/8/2025
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$55.00 ➝ $61.00
5/5/2025
Envista Holdings Corporation stock logo
NVST
Envista
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$21.00 ➝ $18.00
5/2/2025
Envista Holdings Corporation stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$21.00
4/30/2025
Envista Holdings Corporation stock logo
NVST
Envista
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.00 ➝ $17.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Embecta Corp. stock logo
EMBC
Embecta
$1.12B0.50$3.34 per share2.89($12.80) per share-0.75
LivaNova PLC stock logo
LIVN
LivaNova
$1.25B1.99$4.24 per share10.79$24.31 per share1.88
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$219.86M8.48$2.39 per share34.57$15.00 per share5.50
Envista Holdings Corporation stock logo
NVST
Envista
$2.51B1.33$1.66 per share11.84$17.05 per share1.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Embecta Corp. stock logo
EMBC
Embecta
$78.30M$0.9010.713.140.614.89%-19.67%12.27%8/8/2025 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
$63.23M-$4.09N/A14.57N/A-17.41%13.67%6.68%7/30/2025 (Estimated)
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$44.04M$1.9841.7038.052.1819.96%13.53%9.78%7/30/2025 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
-$1.12B-$6.53N/A16.271.25-44.90%4.07%2.25%8/6/2025 (Estimated)

Latest EMBC, NVST, LIVN, and LMAT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q2 2025
Embecta Corp. stock logo
EMBC
Embecta
$0.66$0.70+$0.04$0.40$261.77 million$259.00 million
5/1/2025Q1 2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.50$0.48-$0.02$0.48$57.61 million$59.87 million
5/1/2025Q1 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.20$0.24+$0.04$0.10$608.17 million$616.90 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Embecta Corp. stock logo
EMBC
Embecta
$0.606.22%N/A66.67%N/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.800.97%N/A40.40%14 Years
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A

Latest EMBC, NVST, LIVN, and LMAT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2025
Embecta Corp. stock logo
EMBC
Embecta
quarterly$0.154.51%5/28/20255/28/20256/13/2025
4/29/2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
quarterly$0.201%5/15/20255/15/20255/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Embecta Corp. stock logo
EMBC
Embecta
N/A
2.48
1.83
LivaNova PLC stock logo
LIVN
LivaNova
0.53
1.58
1.37
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.48
16.49
13.83
Envista Holdings Corporation stock logo
NVST
Envista
0.43
2.12
1.82

Institutional Ownership

CompanyInstitutional Ownership
Embecta Corp. stock logo
EMBC
Embecta
93.83%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
Envista Holdings Corporation stock logo
NVST
Envista
N/A

Insider Ownership

CompanyInsider Ownership
Embecta Corp. stock logo
EMBC
Embecta
0.42%
LivaNova PLC stock logo
LIVN
LivaNova
0.29%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
9.50%
Envista Holdings Corporation stock logo
NVST
Envista
1.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Embecta Corp. stock logo
EMBC
Embecta
2,10058.44 million58.20 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.53 million54.37 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
49022.59 million20.45 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,300169.49 million167.28 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Embecta stock logo

Embecta NASDAQ:EMBC

$9.64 +0.36 (+3.88%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$9.78 +0.14 (+1.45%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$45.75 -0.05 (-0.11%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$45.98 +0.23 (+0.49%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

LeMaitre Vascular stock logo

LeMaitre Vascular NASDAQ:LMAT

$82.57 +0.17 (+0.21%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$82.96 +0.39 (+0.47%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Envista stock logo

Envista NYSE:NVST

$19.68 +0.04 (+0.18%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$19.96 +0.28 (+1.40%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.